川崎病合并冠状动脉病变研究进展
Research Progress of Coronary Artery Lesion in Kawasaki Disease
DOI: 10.12677/ACM.2023.1361304, PDF,  被引量   
作者: 王 涛, 易岂建*:重庆医科大学附属儿童医院心血管内科,国家儿童健康与疾病临床医学研究中心,重庆
关键词: 川崎病冠状动脉病变发病机制诊断治疗Kawasaki Disease Coronary Artery Lesion Pathogenesis Diagnosis Treatment
摘要: 冠状动脉病变为儿童川崎病最常见最严重的并发症,约20%未经治疗的川崎病合并冠状动脉病变,后期可能合并冠状动脉血栓、狭窄,严重者出现心肌缺血梗死。本文就川崎病合并冠状动脉病变的流行病学特点、发病机制、判断标准及治疗进行综述,以期加深临床医师对川崎病合并冠状动脉病变的认识。
Abstract: Coronary artery lesion is the most common and serious complication of Kawasaki disease in chil-dren. About 20% of untreated Kawasaki disease have coronary artery lesion. Late acute stage may be complicated with coronary thrombosis and stenosis. Myocardial ischemia infarction occurs in severe cases. This article reviews the epidemiological characteristics, pathogenesis, criteria and treatment of Kawasaki disease complicated with coronary artery lesion, to deepen the clinician’s understanding of coronary artery disease.
文章引用:王涛, 易岂建. 川崎病合并冠状动脉病变研究进展[J]. 临床医学进展, 2023, 13(6): 9320-9324. https://doi.org/10.12677/ACM.2023.1361304

参考文献

[1] Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children: Clinical Observations of 50 Cases. Japanese Journal of Allergology, 16, 178-222. (In Japanese)
[2] Ae, R., Makino, N., Kosami, K., et al. (2020) Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. The Journal of Pediatrics, 225, 23-29. [Google Scholar] [CrossRef] [PubMed]
[3] Kitano, N., Takeuchi, T., Suenaga, T., et al. (2021) Seasonal Vari-ation in Epidemiology of Kawasaki Disease-Related Coronary Artery Abnormalities in Japan, 1999-2017. Journal of Epidemiology, 31, 132-138. [Google Scholar] [CrossRef
[4] Piram, M. (2021) Epidemiology of Kawasaki Disease in Europe. Frontiers in Pediatrics, 9, Article ID: 673554. [Google Scholar] [CrossRef] [PubMed]
[5] Ae, R., Makino, N., Kuwabara, M., et al. (2022) Incidence of Ka-wasaki Disease before and after the COVID-19 Pandemic in Japan: Results of the 26th Nationwide Survey, 2019 to 2020. JAMA Pediatrics, 176, 1217-1224. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, C.Y., Huang, S.H., Chien, K.J., et al. (2022) Reap-praisal of VEGF in the Pathogenesis of Kawasaki Disease. Children (Basel), 9, Article No. 1343. [Google Scholar] [CrossRef] [PubMed]
[7] Huang, C., Wang, W., Huang, H., et al. (2022) Kawasaki Disease: Ubiquitin-Specific Protease 5 Promotes Endothelial Inflammation via TNFα-Mediated Signaling. Pediatric Research. [Google Scholar] [CrossRef] [PubMed]
[8] Weng, K.P., Chien, K.J., Huang, S.H., et al. (2022) iTRAQ Pro-teomics Identified the Potential Biomarkers of Coronary Artery Lesion in Kawasaki Disease and in Vitro Studies Demon-strated That S100A4 Treatment Made HCAECs More Susceptible to Neutrophil Infiltration. International Journal of Molecular Sciences, 23, Article No. 12770. [Google Scholar] [CrossRef] [PubMed]
[9] Kim, S.H. (2022) Diagnosis of Coronary Artery Abnormalities in Kawasaki Disease: Recent Guidelines and z Score Systems. Clinical and Experimental Pediatrics, 65, 430-438. [Google Scholar] [CrossRef] [PubMed]
[10] Singhal, M., Pilania, R.K., Jindal, A.K., et al. (2023) Distal Coronary Artery Abnormalities in Kawasaki Disease: Experience on CT Coronary Angiography in 176 Children. Rheumatology (Oxford), 62, 815-823. [Google Scholar] [CrossRef] [PubMed]
[11] Mossberg, M., Mohammad, A.J., Kahn, F., et al. (2021) High Risk of Coronary Artery Aneurysm in Kawasaki Disease. Rheumatology (Oxford), 60, 1910-1914. [Google Scholar] [CrossRef] [PubMed]
[12] van Stijn, D., Korbee, J.M., Netea, S.A., et al. (2022) Treatment and Coronary Artery Aneurysm Formation in Kawasaki Disease: A Per-Day Risk Analysis. The Journal of Pediatrics, 243, 167-172. [Google Scholar] [CrossRef] [PubMed]
[13] Ae, R., Maddox, R.A., Abrams, J.Y., et al. (2021) Kawasaki Disease with Coronary Artery Lesions Detected at Initial Echocardiography. Journal of the American Heart Association, 10, e19853. [Google Scholar] [CrossRef
[14] Chidambaram, A.C., Ramamoorthy, J.G. and Anan-tharaj, A. (2023) Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children with Kawasaki Dis-ease. Indian Pediatrics, 60, 207-211. [Google Scholar] [CrossRef
[15] Liu, J., Huang, Y., Chen, C., et al. (2022) Risk Factors for Re-sistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population with Kawasaki Disease: A Retrospective Cohort Study. Frontiers in Pediatrics, 10, Article ID: 812644. [Google Scholar] [CrossRef] [PubMed]
[16] Kim, J.J., Kim, H.J., Yu, J.J., et al. (2021) IgA Levels Are Associ-ated with Coronary Artery Lesions in Kawasaki Disease. Korean Circulation Journal, 51, 267-278. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, L., Yang, Y., Cui, Q., et al. (2021) Evaluating the Added Predic-tive Ability of MMP-9 in Serum for Kawasaki Disease with Coronary Artery Lesions. Journal of Investigative Medicine, 69, 13-19. [Google Scholar] [CrossRef] [PubMed]
[18] Cheng, Z., Weng, H., Zhang, J., et al. (2022) The Relationship be-tween Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children with Kawasaki Disease. Frontiers in Pediatrics, 10, Article ID: 854079. [Google Scholar] [CrossRef] [PubMed]
[19] Yan, F., Pan, B., Sun, H., et al. (2019) Risk Factors of Coronary Artery Abnormality in Children with Kawasaki Disease: A Systematic Review and Meta-Analysis. Frontiers in Pediat-rics, 7, Article No. 374. [Google Scholar] [CrossRef] [PubMed]
[20] Friedman, K.G., Gauvreau, K., Baker, A., et al. (2021) Primary Ad-junctive Corticosteroid Therapy Is Associated with Improved Outcomes for Patients with Kawasaki Disease with Coro-nary Artery Aneurysms at Diagnosis. Archives of Disease in Childhood, 106, 247-252. [Google Scholar] [CrossRef] [PubMed]
[21] Aslani, N., Raeeskarami, S.R., Aghaei-Moghadam, E., et al. (2022) Intravenous Methylprednisolone Pulse Therapy versus Intravenous Immunoglobulin in the Prevention of Coro-nary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial. Cureus, 14, e26252. [Google Scholar] [CrossRef] [PubMed]
[22] Portman, M.A., Dahdah, N.S., Slee, A., et al. (2019) Etanercept with IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial. Pediatrics, 143, e20183675. [Google Scholar] [CrossRef] [PubMed]
[23] 中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会. 川崎病冠状动脉病变的临床处理建议(2020年修订版) [J]. 中华儿科杂志, 2020, 58(9): 718-724.
[24] Watanabe, M., Fukazawa, R., Kamisago, M., et al. (2022) Prognosis of Coronary Artery Bypass Grafting in Preschool-Aged Pa-tients with Myocardial Ischemia Due to Giant Aneurysm of Kawasaki Disease. Journal of Clinical Medicine, 11, Article No. 1421. [Google Scholar] [CrossRef] [PubMed]
[25] Kuo, H.C. (2022) Hydrogen Gas Inhalation Regressed Coro-nary Artery Aneurysm in Kawasaki Disease-Case Report and Article Review. Frontiers in Cardiovascular Medicine, 9, Article ID: 895627. [Google Scholar] [CrossRef] [PubMed]
[26] Tsuda, E. and Hashimoto, S. (2021) Time Course of Coronary Ar-tery Aneurysms in Kawasaki Disease. The Journal of Pediatrics, 230, 133-139. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, X., He, Y., Shao, Y., et al. (2021) Factors Affecting the Duration of Coronary Artery Lesions in Patients with the Kawasaki Disease: A Retrospective Cohort Study. Pediatric Rheumatology Online Journal, 19, Article No. 96. [Google Scholar] [CrossRef] [PubMed]